CUSIP: 89365K305
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,925,000
-
Share change
-
+267,816
-
Total reported value
-
$3,869,000
-
Price per share
-
$2.01
-
Number of holders
-
10
-
Value change
-
+$387,126
-
Number of buys
-
4
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP 89365K305?
CUSIP 89365K305 identifies TBIO - TRANSGENOMIC INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2015
-
Previous quarter:
Q3 2014
Recent filing periods for CUSIP 89365K305:
Institutional Holders of TRANSGENOMIC INC - COM NEW (TBIO) as of Q4 2014
As of 31 Dec 2014,
TRANSGENOMIC INC - COM NEW (TBIO) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,925,000 shares.
The largest 10 holders included
Third Security, LLC, WHITE PINE CAPITAL LLC, Potomac Capital Management, Inc., FMR LLC, PERCEPTIVE ADVISORS LLC, HighTower Advisors, LLC, GOLDMAN SACHS GROUP INC, WELLS FARGO & COMPANY/MN, UBS Group AG, and BANK OF AMERICA CORP /DE/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.